Nasopharyngeal carcinoma (NPC) is a type of cancer that develops in the nasopharynx, which is the upper part of the throat behind the nose. It is relatively rare in most parts of the world but is more common in certain regions, particularly in Southeast Asia, North Africa, and Alaska. NPC is often associated with the Epstein-Barr virus (EBV) and is more common in individuals of Chinese and Southeast Asian descent. Symptoms of NPC can include a persistent sore throat, difficulty swallowing, ear pain, and a lump in the neck. Treatment for NPC typically involves a combination of radiation therapy, chemotherapy, and sometimes surgery. Prognosis for NPC can vary depending on the stage at which it is diagnosed and how quickly it is treated. Research in the field of nasopharyngeal carcinoma focuses on understanding the risk factors, genetic factors, and molecular mechanisms underlying the development of the disease. This includes studying the role of EBV in NPC, as well as identifying potential biomarkers for early detection and targeted therapies for the disease. Overall, research in NPC aims to improve outcomes for patients through better understanding of the disease and more effective treatment strategies.